Foundayo (Orforglipron)

Foundayo 0.8 mg contains orforglipron, an oral GLP-1 receptor agonist used for weight management in eligible adults with obesity or overweight accompanied by weight-related medical conditions. It is taken once daily alongside a reduced-calorie diet and increased physical activity, as prescribed by a healthcare professional.

Key Features & Specifications

Active ingredient: Orforglipron
Medicine class: GLP-1 receptor agonist
Strength: 0.8 mg
Form: Film-coated tablet
Administration: Oral
Frequency: Once daily
Use: Weight management
Pack size: 30 tablets
Manufacturer: Eli Lilly
Prescription: Yes

Price range: €100,00 through €155,00

Dosage	Clear

Compare

Add to wishlist

SAVE 15%

more 2 products

SAVE 50%

6 for the price of 3

* The information on this page is a summary and is not intended to cover all available information about this medication. It does not cover all possible uses, directions, precautions, drug interactions or adverse effects and is not a substitute for the expertise and judgement of your healthcare professional.